EM2108C "Oxalate Crystallopathy" (IM GR-081321)
Learn the pathophysiology of oxalate crystallopathies, and highlight selected recent treatment strategies.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Name some aspects of chemistry of oxalate.
- Recognize some basic biology of oxalate as a metabolic end product.
- Identify the classes of oxalate-related diseases.
- Describe the etiology and pathophysiology of oxalate crystallopathies.
- Define the recent developments in therapy of oxalate crystallopathies.
Orson Moe, M.D.
Professor, Departments of Internal Medicine and Physiology
Division of Nephrology
Director, Pak Center for Metabolism and Clinical Research
Director, O’Brien Kidney Research Center
- 1.00 AMA